Skip to Main Content
Cancer HealthCast 29m listen

Cancer HealthCast: New Technologies Lead to Major Breakthroughs in Cancer Detection, Screening at NCI

Two key programs are playing a vital role in detecting and diagnosing cancer as well as reducing the overall burden on patients and their families.

The National Cancer Institute is utilizing a host of new technologies to diagnose and detect cancer thanks to its Innovative Molecular Analysis Technologies (IMAT) and Informatics Technology for Cancer Research (ITCR) programs. These programs are developing methods that are enhancing cancer research, including artificial intelligence.

Dr. Kelly Crotty, program director for NCI’s Center for Strategic Scientific Initiatives, said not only have the programs helped researchers better identify and screen for cancer, but also they’ve been instrumental in driving progress in clinical care. Crotty also shares updates about NCI’s Liquid Biopsy Consortium and discusses the benefits and challenges she’s seeing with AI.

Related Content
Woman typing at computer

Stay in the know

Subscribe now to receive our curated newsletters